| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.06B | 1.68B | 1.89B | 2.11B | 1.70B | 1.53B |
| Gross Profit | 639.67M | 1.00B | 1.09B | 1.20B | 1.05B | 927.96M |
| EBITDA | 43.24M | 89.22M | 95.34M | 135.28M | 173.96M | 154.39M |
| Net Income | -73.45M | -20.33M | -15.29M | 36.61M | 81.84M | 69.54M |
Balance Sheet | ||||||
| Total Assets | 749.39M | 860.81M | 950.88M | 953.94M | 806.04M | 470.14M |
| Cash, Cash Equivalents and Short-Term Investments | 1.26M | 1.95M | 2.54M | 1.79M | 1.59M | 1.61M |
| Total Debt | 940.71M | 936.11M | 972.65M | 896.01M | 588.65M | 199.60M |
| Total Liabilities | 1.27B | 1.31B | 1.39B | 1.39B | 965.47M | 579.69M |
| Stockholders Equity | -521.34M | -451.59M | -441.93M | -438.18M | -159.43M | -109.55M |
Cash Flow | ||||||
| Free Cash Flow | -16.73M | 3.64M | -66.08M | -33.32M | 129.92M | 86.03M |
| Operating Cash Flow | -4.84M | 27.14M | -9.03M | 36.14M | 189.16M | 131.54M |
| Investing Cash Flow | -15.17M | -26.29M | -58.35M | -70.61M | -56.62M | -45.24M |
| Financing Cash Flow | 19.32M | -1.44M | 68.13M | 33.87M | -132.56M | -88.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | $614.02M | 13.07 | 9.96% | 7.06% | -4.61% | -25.66% | |
64 Neutral | $1.33B | 14.75 | 9.09% | 2.80% | 2.18% | -22.35% | |
62 Neutral | $1.21B | 5.55 | 26.20% | 2.29% | -6.03% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | $1.06B | ― | -1.18% | 4.39% | 5.37% | -127.27% | |
48 Neutral | $87.51M | -1.03 | -9999.00% | ― | -9.47% | 48.11% | |
39 Underperform | $120.46M | ― | ― | ― | -16.95% | -88.00% |
On November 4, 2025, Sleep Number Corporation executed a Twelfth Amendment to its Credit and Security Agreement, extending the maturity date to December 3, 2027, and adjusting various financial covenants and credit facilities. This amendment signifies a strategic financial restructuring for the company, ensuring compliance with all covenants and facilitating the retirement of Board member Stephen L. Gulis, Jr., who stepped down following the amendment’s qualification as a debt refinancing.
The most recent analyst rating on (SNBR) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on Sleep Number stock, see the SNBR Stock Forecast page.